IDSA, ASM outline role of SARS-CoV-2 sequencing in clinical settings

idsa asm outline role of sars cov 2 sequencing in clinical settings

Sumary of IDSA, ASM outline role of SARS-CoV-2 sequencing in clinical settings:

  • November 15, 2021 2 min read Source/Disclosures Published by: Disclosures: Greninger reports having a relationship with Abbott Molecular and has received funding from Gilead Sciences and Merck outside of the submitted work.
  • Please see the review for all other authors’ relevant financial disclosures.
  • ” Photo source: Adobe stock They said allele-specific RT-qPCR has “emerged as a potential solution for identifying SARS-CoV-2 variants with potential therapeutic implications,” because of its fast turnaround time and the ability to focus on mutational hotspots.
  • Whole-genome sequencing allows clinicians to determine the full nucleotide sequence, either for the whole viral genome or for a specific region that contains most of the “known medically relevant mutation sites.
  • Lee, MD, an associate professor of internal medicine at the University of Texas Southwestern Medical Center in Dallas and a co-author of the review, said in a press release.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.